Table 1.
Factors related to clinical practice guidelines (CPGs).
| Items of the questionnaire | Total number | Number of responses (%) | ||
|---|---|---|---|---|
| Disagree (moderately disagree/strongly disagree) (Likert 1-2) | Neither agree nor disagree (Likert 3) | Agree (moderately agree/strongly agree) (Likert 4-5) | ||
| (i) The evolution of the research, given that sometimes there are subsequent findings that are proven uncertain or irreproducible, may reduce the credibility of the CPG recommendations | 96 | 20 (20.8) | 5 (5.2) | 71 (74.0) |
| (ii) The complexity of the process recommended in the CPG difficults adherence | 96 | 48 (50.0) | 6 (6.3) | 42 (43.8) |
| (iii) Scientific advances organized in the form of guidelines and recommendations are an invaluable help for clinicians | 98 | 2 (2.0) | 2 (2.0) | 94 (95.9)∗ |
| (iv) The objective of the guidelines is to provide an up-to-date informative framework that helps the clinician to make the most appropriate decisions individually for each patient | 98 | 3 (3.0) | 1 (1.0) | 94 (95.9)∗ |
| (v) The dynamic nature of scientific knowledge implies the periodic reassessment of the CPGs | 98 | 2 (2.0) | 0 | 96 (97.9)∗ |
| (vi) An effective dissemination of the CPGs and their updates is necessary | 98 | 2 (2.0) | 0 | 96 (97.9)∗ |
| (vii) There are different CPGs whose recommendations do not coincide | 96 | 13 (13.6) | 6 (6.3) | 77 (80.2)† |
| (viii) Although a guide is well implemented it is difficult to maintain it, since after a certain time professionals tend to return to their previous routines | 96 | 66 (68.8) | 6 (6.3) | 24 (25.0) |
| (ix) It is crucial to incorporate adherence indicators to the CPGs | 96 | 4 (4.2) | 6 (6.3) | 86 (89.6)† |
| (x) The large number of CPGs on diabetes may prevent effective dissemination | 96 | 6 (6.3) | 4 (4.2) | 86 (89.6)† |
∗Consensus achieved in the first Delphi round; †consensus achieved in the second Delphi round.